Xylem (XYL) Earns Buy Rating from Cowen

Share on StockTwits

Xylem (NYSE:XYL)‘s stock had its “buy” rating reiterated by analysts at Cowen in a research note issued to investors on Friday. They currently have a $85.00 target price on the industrial products company’s stock. Cowen’s price target suggests a potential upside of 21.83% from the company’s previous close.

Several other equities research analysts have also recently issued reports on XYL. BMO Capital Markets lifted their target price on Xylem from $83.00 to $84.00 and gave the stock an “outperform” rating in a report on Wednesday, August 1st. Canaccord Genuity set a $78.00 target price on Xylem and gave the stock a “hold” rating in a report on Tuesday, July 24th. Zacks Investment Research cut Xylem from a “hold” rating to a “sell” rating in a report on Monday, July 16th. Berenberg Bank began coverage on Xylem in a report on Wednesday, October 3rd. They issued a “sell” rating and a $65.00 target price on the stock. Finally, Oppenheimer reaffirmed a “buy” rating on shares of Xylem in a report on Tuesday, July 31st. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and nine have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average target price of $82.08.

NYSE:XYL opened at $69.77 on Friday. The company has a current ratio of 1.43, a quick ratio of 1.02 and a debt-to-equity ratio of 0.86. The stock has a market cap of $14.35 billion, a price-to-earnings ratio of 29.07, a price-to-earnings-growth ratio of 1.52 and a beta of 1.22. Xylem has a 52 week low of $62.24 and a 52 week high of $82.44.

Xylem (NYSE:XYL) last issued its earnings results on Tuesday, July 31st. The industrial products company reported $0.73 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.71 by $0.02. Xylem had a return on equity of 19.04% and a net margin of 7.39%. The firm had revenue of $1.32 billion for the quarter, compared to analysts’ expectations of $1.28 billion. During the same period in the previous year, the firm posted $0.59 earnings per share. The business’s revenue was up 13.1% compared to the same quarter last year. As a group, analysts predict that Xylem will post 2.91 earnings per share for the current fiscal year.

In related news, SVP Kairus Tarapore sold 18,800 shares of Xylem stock in a transaction dated Friday, August 3rd. The stock was sold at an average price of $75.17, for a total value of $1,413,196.00. Following the completion of the transaction, the senior vice president now owns 31,580 shares in the company, valued at $2,373,868.60. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Paul A. Stellato sold 1,500 shares of Xylem stock in a transaction dated Wednesday, September 19th. The stock was sold at an average price of $82.00, for a total value of $123,000.00. Following the completion of the transaction, the insider now owns 12,796 shares of the company’s stock, valued at approximately $1,049,272. The disclosure for this sale can be found here. In the last quarter, insiders sold 49,284 shares of company stock valued at $3,839,982. 0.81% of the stock is currently owned by company insiders.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in XYL. Sei Investments Co. grew its position in Xylem by 4.2% in the first quarter. Sei Investments Co. now owns 64,025 shares of the industrial products company’s stock worth $4,925,000 after acquiring an additional 2,598 shares in the last quarter. GSA Capital Partners LLP purchased a new position in shares of Xylem during the first quarter valued at approximately $282,000. Caisse DE Depot ET Placement DU Quebec boosted its position in shares of Xylem by 97.6% during the first quarter. Caisse DE Depot ET Placement DU Quebec now owns 8,924 shares of the industrial products company’s stock valued at $686,000 after buying an additional 4,407 shares during the period. Nomura Asset Management Co. Ltd. boosted its position in shares of Xylem by 3.2% during the first quarter. Nomura Asset Management Co. Ltd. now owns 27,174 shares of the industrial products company’s stock valued at $2,091,000 after buying an additional 831 shares during the period. Finally, UBS Group AG boosted its position in shares of Xylem by 11.8% during the first quarter. UBS Group AG now owns 283,181 shares of the industrial products company’s stock valued at $21,782,000 after buying an additional 29,969 shares during the period. Institutional investors own 85.85% of the company’s stock.

Xylem Company Profile

Xylem Inc engages in the design, manufacture, and service of engineered solutions for the water and wastewater applications. It operates through three segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps, and controls and systems, as well as filtration, disinfection, and biological treatment equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation, treatment, and testing of water and wastewater applications.

Further Reading: What is an Initial Public Offering (IPO)?

Analyst Recommendations for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply